60 likes | 62 Views
Global Market Insights recently added a detailed market research study focused on the Global Glucose Biosensors Market across the global, regional and country level. The report provides 360u00c2u00b0 analysis of Glucose Biosensors Market from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Glucose Biosensors market and estimates the future trend of Global Glucose Biosensors industry on the basis of this detailed study.
E N D
Glucose Biosensors Market Analysis & Forecast to 2030 by Key Players, Share, Trend, Segmentation © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Market Scenario of Glucose Biosensors Market • Global Market Insights recently introduced report on Global Glucose Biosensors Market Report is an in-depth study providing complete analysis of the industry for the period 2022 to 2030. • It provides complete overview of Global Glucose Biosensors industry considering all the major industry trends, market dynamics and competitive scenario. • Several renowned industry players in the glucose biosensors industry are substantially investing in research and development to enhance product innovation and meet consumer demand. • Back in April 2022, Ascensia Diabetes Care, a leading international diabetes care corporation, announced the launch of its next-gen Eversense® E3 Continuous Glucose Monitoring (CGM) System, as well as the latest savings program known as Eversense PASS. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Continue:- • Earlier this year, Eversense E3, created by Senseonics Holdings, Inc., received US Food and Drug Administration (FDA) approval for use for a maximum of six months, which made it the longest-lasting CGM sensor available on the market. • The glucose biosensors market has been bifurcated in terms of product, technology, end-users, and region. • Based on product, the glucose biosensors market has been categorized into continuous glucose monitoring (CGM) as well as self-monitoring blood glucose (SMBG). • In 2021, the SMBG segment registered a market valuation of approximately $5 billion and is projected to gain significant momentum in the forecast timeframe owing to increasing awareness around diabetes complications, risks, control, and management. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
360° Industry Analysis • Based on technology, the industry has been divided into electrochemical biosensors and optical biosensors. • The electrochemical biosensors segment is anticipated to register a CAGR of around 12.8% through the forecast period, driven by the rising number of new product launches and innovations, which will further drive product demand. • With respect to end-users, the glucose biosensors market has been segmented into hospitals, home care, diagnostic centers & clinic, and others. • The hospitals segment is set to grow with a robust CAGR of nearly 12.9% over the review timeline. The increasing number of diabetic patients around the globe and the numerous complications associated with the disease would foster segment outlook. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Key Players are • Ascensia Diabetes Care Holdings AG. (Senseonics Inc.) • Lifescan Inc. • Universal Biosensors • Nova Biomedical • Med Trust • Taidoc Technology Corporation • Roche AG. • Dexcom • i-SENS Inc. • Abbott • Trividia Health • Pinnacle technology • Browse Complete Summary of this report @ https://www.gminsights.com/industry-analysis/glucose-biosensors-market © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com